Literature DB >> 10719732

High telomerase activity and high HTRT mRNA expression differentiate pure myxoid and myxoid/round-cell liposarcomas.

R Schneider-Stock1, V Jaeger, J Rys, J T Epplen, A Roessner.   

Abstract

Molecular markers characterizing the transition of a myxoid to a more round-cell liposarcoma have not been described. To examine whether telomerase activity, hTRT and hTR mRNA expression were associated with tumor progression in myxoid liposarcoma, we investigated a total of 28 myxoid liposarcomas (13 pure myxoid tumors, 14 mixed-type tumors, and 1 pure round-cell variant) from 19 patients. Telomerase activity was detected by using the fluorescent PCR-based TRAP-assay. Expression of hTRT and hTR mRNAs was determined by the semi-quantitative RT-PCR. On the basis of only one tumor sample per patient, telomerase activity was found in 9 of 9 myxoid/round-cell liposarcomas and in 3 of 10 pure myxoid tumors. Elevated hTRT expression was found in 13 of 17 liposarcomas. All telomerase-positive tumors showed hTRT expression, whereas there were 3 cases showing hTRT expression without telomerase activity. HTR mRNA expression was elevated in all 19 liposarcomas. Thus, only the levels of telomerase activity and of hTRT mRNA expression differentiated pure myxoid liposarcoma and myxoid/round-cell liposarcoma (p < 0.003 and p = 0.029, respectively). We believe that high levels of telomerase activity and of hTRT expression are associated with tumor progression from low-grade pure myxoid to higher-grade malignant round-cell liposarcoma, and may consequently represent a useful prognostic marker for this histological sub-type of soft-tissue tumors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10719732     DOI: 10.1002/(sici)1097-0215(20000120)89:1<63::aid-ijc10>3.0.co;2-v

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma.

Authors:  Matthias Krams; Barbara Hero; Frank Berthold; Reza Parwaresch; Dieter Harms; Pierre Rudolph
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

Review 2.  [Identification of genes over-expressed in myxoid/round cell liposarcoma. DNA microarray analysis and immunohistochemical correlation].

Authors:  C Lanckohr; A Kasprzynski; L Klein-Hitpass; H-H Homann; M Lehnhardt; O Müller; C Kuhnen; P Herter
Journal:  Pathologe       Date:  2010-02       Impact factor: 1.011

3.  Influence of telomerase activity on bone and soft tissue tumors.

Authors:  Norifumi Umehara; Toshifumi Ozaki; Shinsuke Sugihara; Toshiyuki Kunisada; Yuki Morimoto; Akira Kawai; Keiichiro Nishida; Aki Yoshida; Takuro Murakami; Hajime Inoue
Journal:  J Cancer Res Clin Oncol       Date:  2004-07       Impact factor: 4.553

4.  Telomerase detection in the diagnosis and prognosis of cancer.

Authors:  Eiso Hiyama; Keiko Hiyama
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

5.  Correlation between p38 mitogen-activated protein kinase and human telomerase reverse transcriptase in sarcomas.

Authors:  Toshihiro Matsuo; Shoji Shimose; Tadahiko Kubo; Jun Fujimori; Yuji Yasunaga; Takashi Sugita; Mitsuo Ochi
Journal:  J Exp Clin Cancer Res       Date:  2012-01-16

6.  TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.

Authors:  Christian Koelsche; Marcus Renner; Wolfgang Hartmann; Regine Brandt; Burkhard Lehner; Nina Waldburger; Ingo Alldinger; Thomas Schmitt; Gerlinde Egerer; Roland Penzel; Eva Wardelmann; Peter Schirmacher; Andreas von Deimling; Gunhild Mechtersheimer
Journal:  J Exp Clin Cancer Res       Date:  2014-04-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.